Eckard Weber

Dr. Eckard Weber is a highly accomplished individual with an extensive background in the field of medicine and biotechnology. He holds a Doctor of Medicine (M.D.) degree from the prestigious University of Ulm Medical School.

Throughout his career, Dr. Weber has held key leadership positions in various organizations, showcasing his expertise and innovative mindset. He has founded and served as the Chief Executive Officer of PrimeFour Therapeutics, Inc., and as the Chief Innovation Officer of Transposon Therapeutics, Inc.

Dr. Weber has also contributed his knowledge and skills as an Entrepreneur in Residence (EIR) at Canaan Partners, as well as an Advisory Partner at Domain Associates. His experience includes being a Partner at Domain Associates and the CEO of Cytovia, Inc.

Notably, Dr. Eckard Weber has also served in academia, holding roles such as Senior Vice President of Research and Development (R&D) at Cocensys, Inc., Professor of Pharmacology at UC Irvine, Professor at Oregon Health Sciences University (Vollum Institute), Assistant Professor at Stanford University School of Medicine, and as a Postdoctoral Fellow at Stanford University School of Medicine.

With his diverse background spanning medical practice, entrepreneurship, venture capital, and academic research, Dr. Weber brings a wealth of experience and expertise to every role he undertakes, driving innovation and success in the biotechnology and healthcare industries.